Cargando…

A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity

This study reports the synthesis, characterization and importance of a novel diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate (MQOAHM). Two independent molecular structures of the disordered MQOAHM have been established by XRD‑single‑crystal analysis in a ratio of 0.596(3...

Descripción completa

Detalles Bibliográficos
Autores principales: Missioui, Mohcine, Said, Musa A., Demirtaş, Güneş, Mague, Joel T., Al-Sulami, Ahlam, Al-Kaff, Nadia S., Ramli, Youssef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627592/
https://www.ncbi.nlm.nih.gov/pubmed/34909067
http://dx.doi.org/10.1016/j.arabjc.2021.103595
_version_ 1784606865372479488
author Missioui, Mohcine
Said, Musa A.
Demirtaş, Güneş
Mague, Joel T.
Al-Sulami, Ahlam
Al-Kaff, Nadia S.
Ramli, Youssef
author_facet Missioui, Mohcine
Said, Musa A.
Demirtaş, Güneş
Mague, Joel T.
Al-Sulami, Ahlam
Al-Kaff, Nadia S.
Ramli, Youssef
author_sort Missioui, Mohcine
collection PubMed
description This study reports the synthesis, characterization and importance of a novel diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate (MQOAHM). Two independent molecular structures of the disordered MQOAHM have been established by XRD‑single‑crystal analysis in a ratio of 0.596(3)/0.404(3), MQOAHM (a) and MQOAHM (b), respectively. MQOAHM was characterized by means of various spectroscopic tools ESI-MS, IR, (1)H &(13)C NMR analyses. Density Functional Theory (DFT) method, B3LYP, 6–311++G(d,p) basis set was used to optimize MQOAHM molecule. The obtained theoretical structure and experimental structure were superimposed on each other, and the correlation between them was calculated. The Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital (LUMO) were created, and the energy gap between these orbitals was calculated. For analyzing intermolecular interactions, Molecular Electrostatic Potential (MEP) and Hirshfeld Surface Analysis were studied. For a fair comparative study, the two forms of the title compound were docked together with 18 approved drugs and N3 under precisely the same conditions. The disordered molecule structure's binding scores against 7BQY were −7.0 and −6.9 kcal/mol(−1) for MQOAHM (a) and MQOAHM (b), respectively. Both the forms show almost identical superimposed structures and scores indicating that the disorder of the molecule, in this study, has no obvious effect. The high binding score of the molecule was attributed to the multi-hydrogen bond and hydrophobic interactions between the ligand and the receptor's active amino acid residues. Worth pointing out here that the aim of using the free energy in Silico molecular docking approach is to rank the title molecule compared to the wide range of approved drugs and a well-established ligand N3. The binding scores of all the molecules used in this study are ranged from −9.9 to −4.5 kcal/mol(−1). These results and the supporting statistical analyses suggest that this malonate-based ligand merits further research in the context of possible therapeutic agents for COVID-19. Cheap computational techniques, PASS, Way2drug and ADMET, online software tools, were used in this study to uncover the title compound's potential biological activities and cytotoxicity.
format Online
Article
Text
id pubmed-8627592
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
record_format MEDLINE/PubMed
spelling pubmed-86275922021-11-29 A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity Missioui, Mohcine Said, Musa A. Demirtaş, Güneş Mague, Joel T. Al-Sulami, Ahlam Al-Kaff, Nadia S. Ramli, Youssef Arab J Chem Original Article This study reports the synthesis, characterization and importance of a novel diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate (MQOAHM). Two independent molecular structures of the disordered MQOAHM have been established by XRD‑single‑crystal analysis in a ratio of 0.596(3)/0.404(3), MQOAHM (a) and MQOAHM (b), respectively. MQOAHM was characterized by means of various spectroscopic tools ESI-MS, IR, (1)H &(13)C NMR analyses. Density Functional Theory (DFT) method, B3LYP, 6–311++G(d,p) basis set was used to optimize MQOAHM molecule. The obtained theoretical structure and experimental structure were superimposed on each other, and the correlation between them was calculated. The Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital (LUMO) were created, and the energy gap between these orbitals was calculated. For analyzing intermolecular interactions, Molecular Electrostatic Potential (MEP) and Hirshfeld Surface Analysis were studied. For a fair comparative study, the two forms of the title compound were docked together with 18 approved drugs and N3 under precisely the same conditions. The disordered molecule structure's binding scores against 7BQY were −7.0 and −6.9 kcal/mol(−1) for MQOAHM (a) and MQOAHM (b), respectively. Both the forms show almost identical superimposed structures and scores indicating that the disorder of the molecule, in this study, has no obvious effect. The high binding score of the molecule was attributed to the multi-hydrogen bond and hydrophobic interactions between the ligand and the receptor's active amino acid residues. Worth pointing out here that the aim of using the free energy in Silico molecular docking approach is to rank the title molecule compared to the wide range of approved drugs and a well-established ligand N3. The binding scores of all the molecules used in this study are ranged from −9.9 to −4.5 kcal/mol(−1). These results and the supporting statistical analyses suggest that this malonate-based ligand merits further research in the context of possible therapeutic agents for COVID-19. Cheap computational techniques, PASS, Way2drug and ADMET, online software tools, were used in this study to uncover the title compound's potential biological activities and cytotoxicity. The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2022-02 2021-11-28 /pmc/articles/PMC8627592/ /pubmed/34909067 http://dx.doi.org/10.1016/j.arabjc.2021.103595 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Missioui, Mohcine
Said, Musa A.
Demirtaş, Güneş
Mague, Joel T.
Al-Sulami, Ahlam
Al-Kaff, Nadia S.
Ramli, Youssef
A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity
title A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity
title_full A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity
title_fullStr A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity
title_full_unstemmed A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity
title_short A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity
title_sort possible potential covid-19 drug candidate: diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2h)-yl)acetyl)hydrazono)malonate: docking of disordered independent molecules of a novel crystal structure, hsa/dft/xrd and cytotoxicity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627592/
https://www.ncbi.nlm.nih.gov/pubmed/34909067
http://dx.doi.org/10.1016/j.arabjc.2021.103595
work_keys_str_mv AT missiouimohcine apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT saidmusaa apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT demirtasgunes apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT maguejoelt apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT alsulamiahlam apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT alkaffnadias apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT ramliyoussef apossiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT missiouimohcine possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT saidmusaa possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT demirtasgunes possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT maguejoelt possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT alsulamiahlam possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT alkaffnadias possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity
AT ramliyoussef possiblepotentialcovid19drugcandidatediethyl2223methyl2oxoquinoxalin12hylacetylhydrazonomalonatedockingofdisorderedindependentmoleculesofanovelcrystalstructurehsadftxrdandcytotoxicity